Filing Details
- Accession Number:
- 0001388658-25-000048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-27 16:07:03
- Reporting Period:
- 2023-11-30
- Filing Date:
- 2025-02-27
- Accepted Time:
- 2025-02-27 16:07:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1388658 | Irhythm Technologies Inc. | IRTC | Surgical & Medical Instruments & Apparatus (3841) | 208149544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850687 | Sumi Shrishrimal | C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103 | Evp, Chief Risk Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-30 | 166 | $72.49 | 23,464 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2024-05-31 | 186 | $74.98 | 23,650 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2024-11-29 | 110 | $71.46 | 23,760 | No | 5 | J | Direct | |
| Common Stock | Acquisiton | 2025-02-25 | 15,293 | $0.00 | 39,053 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2025-02-26 | 6,732 | $0.00 | 45,785 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2025-02-26 | 7,942 | $112.13 | 37,843 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | J | Direct | |
| No | 5 | J | Direct | |
| No | 5 | J | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2022 through November 30, 2023. This transaction is exempt from Section 16(b) under Rule 16b-3.
- Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period December 1, 2023 through May 31, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3.
- Ms. Shrishrimal is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2016 Employee Stock Purchase Plan for the purchase period June 1, 2024 through November 30, 2024. This transaction is exempt from Section 16(b) under Rule 16b-3.
- Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that the performance conditions were met with respect toperformance Restricted Stock Units ("RSUs") granted to the Reporting Person on May 24, 2022.
- These securities are RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs vest on March 1, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
- These shares were sold to cover tax withholding and remittance obligations in connection with the vesting of performance RSUs.
Billionaire Hedge Funds
